Multicenter Dose-escalation Study of a Combination of Pazopanib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid Tumors

Clinical trial NCT01202032 · COMPLETED

Trial details

NCT number: NCT01202032
Sponsor: Centre Leon Berard
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Renal Cell Carcinoma Advanced Refractory Solid Tumors Histologically or Cytologically Confirmed

Start date: 2010-07-01
Primary completion: 2013-01-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.